Tag Carbone Cancer Center
Common chemotherapy drugs don’t work like doctors thought, with big implications for drug discovery
Findings reveal the likely reason why certain chemotherapies are effective for many patients. Importantly, they also help explain why attempts to find new chemo drugs based solely on stopping cellular division have been so disappointing.
UW researchers identify cell type that could be key to preventing marrow transplant complication
UW researchers at the Carbone Cancer Center have identified the cells that can cause graft-versus-host disease, the most common complication of bone marrow transplants.
Breast cancer researchers learn how to teach an old drug new tricks to help patients
UW researchers have uncovered a key feature of breast cancers that renders them either vulnerable or resistant to paclitaxel treatment, which could help identify which patients are most likely to see success.
A new way to help the immune system fight back against cancer
"We believe we are launching a new cancer therapy field here," says Jamey Weichert, professor of radiology. "It’s very exciting, and the research team is incredible.”
UW Health March 19 Daily Update: Caring for Cancer Patients
The University of Wisconsin Carbone Cancer Center continues to care for cancer patients by using telehealth technology, expanding screening, and extending in-home care options to address the unique challenges created by the COVID-19 pandemic.
Remembering Heidi Dvinge
On Sept. 20, Professor Heidi Dvinge passed away unexpectedly. Her colleagues describe her tragic loss as “devastating.”
Researchers probe cell division defects to gain insight into cancer
Colleagues at the UW Carbone Cancer Center are leading efforts to better understand how chromosome segregation goes wrong and contributes to disease.
Blood-based screen for colon cancer shows promise
The scientists expect their findings will ultimately lead to a blood test for the cancer, adding a method to help increase screening rates while reducing overtreatment.
Personalized in vitro model enables drug screening for kidney cancer
One way to treat the most common type of kidney cancer is to use anti-angiogenic drugs to cut off the blood supply to the tumors, but patients respond differently to the drugs, and choosing the wrong one can make the cancer grow faster.
The Ride gets research into gear
The Ride is a signature cycling event that premiered in September 2016, sending hundreds of riders across eastern Dane County to raise money for cancer research on the UW–Madison campus.
Study of inflammation’s link to diseases wins NIH grant
Inflammation "is likely implicated in almost every disease,” says researcher David Beebe — including cancer, cardiovascular conditions and autoimmune diseases.
Long-term cancer survivor beats odds, prompts study
The unusual case of Margaret “Peg” Geisler has inspired an international search for “extreme survivors” of metastatic breast cancer. “They never teach you about patients like Peg in medical school," says UW Health oncologist Mark Burkard.
New study shows how cells can be led down non-cancer path
As cells with a propensity for cancer break down food for energy, they reach a fork in the road: They can either continue energy production as healthy cells, or shift to the energy production profile of cancer cells.
UW-Madison advisory board aids cancer treatment statewide
The Precision Medicine Molecular Tumor Board has a dual mission: consulting with oncologists statewide about targeted drugs to battle out-of-control cancers; and amassing data on what works and what does not.
Photo gallery: Andy North and friends have fun, raise $1 million for Carbone Cancer Center
Professional golfer Andy North and his friends raised more than $1 million for the University of Wisconsin Carbone Cancer Center at a dinner and golf tournament this week
Morgridge, UW researcher scores in cancer research ‘lightning round’
Scientists get funded for their ideas through a marathon grant-writing process, scores of collaborators, weeks of information gathering and a final product that often tops 250 pages. Melissa Skala’s experience was different: two people, 250 words, in 24 hours.
Protein’s flexibility helps its response to diverse pollutants
How some industrial pollutants or abnormal levels of cellular metabolites contribute to diverse human diseases is now more clearly understood, based on a new study from the University of Wisconsin Carbone Cancer Center (UWCCC) and the McArdle Laboratory for Cancer Research.
Immunotherapy team harnesses cellular systems to fight diseases
A dedicated army of UW–Madison researchers is perfecting how to use immunotherapy and searching for new ways to do so.